全球酵素免疫分析法（ELISA）檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計酵素免疫分析法(ELISA) 檢測市場將從 2025 年的 35.9 億美元成長到 2034 年的 78.1 億美元，2026 年至 2034 年的複合年成長率為 9.02%。

由於酵素免疫分析法（ELISA）在疾病診斷和生物醫學研究中的廣泛應用，全球ELISA市場正經歷強勁成長。 ELISA是一種用於檢測生物檢體中抗體、抗原和蛋白質的實驗室技術。它常用於感染疾病、自體免疫疾病和癌症生物標記的診斷。

推動市場發展的主要因素之一是對準確可靠的診斷測試日益成長的需求。醫療機構和實驗室高度依賴酵素連結免疫吸附試驗（ELISA），因為其具有高靈敏度和特異性。此外，生物技術研發投入的增加以及先進診斷技術的開發也促進了市場成長。

隨著全球對快速高效診斷解決方案的需求不斷成長，ELISA檢測市場預計將持續成長。檢查室自動化和多重檢測技術的進步有望提高檢測效率。在全球醫療體係日益重視疾病早期檢測和個人化醫療的背景下，ELISA檢測將繼續在診斷和研究中發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球酵素免疫分析法試驗 (ELISA) 市場：依試驗類型分類

• 市場分析、洞察與預測
• 夾心ELISA
• 間接ELISA
• 多用途和可攜式乙二醇
• 競爭性ELISA

第5章 全球酵素免疫分析法試驗 (ELISA) 市場：依應用分類

• 市場分析、洞察與預測
• 免疫學
• 發炎
• 感染疾病
• 癌症
• 蛋白質定量
• 其他

第6章 全球酵素免疫分析法試驗 (ELISA) 市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific. Inc
  • American Laboratory Products Company（ALPCO）
  • BD Biosciences
  • Bio-Rad Laboratories Inc
  • BioMerieux
  • Ortho-Clinical Diagnostics Inc
  • R & D Systems Inc
  • ZEUS Scientific Inc
  • Enzo Life Sciences, Inc
  • Biolegand, Inc

The Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market size is expected to reach USD 7.81 Billion in 2034 from USD 3.59 Billion (2025) growing at a CAGR of 9.02% during 2026-2034.

The global enzyme-linked immunosorbent assay (ELISA) testing market is experiencing strong growth due to its widespread use in disease diagnosis and biomedical research. ELISA is a laboratory technique used to detect antibodies, antigens, and proteins in biological samples. It is commonly used in the diagnosis of infectious diseases, autoimmune disorders, and cancer biomarkers.

One of the major drivers of the market is the increasing demand for accurate and reliable diagnostic testing. Healthcare providers and research laboratories rely heavily on ELISA tests because they offer high sensitivity and specificity. Additionally, rising investments in biotechnology research and the development of advanced diagnostic technologies are boosting the market.

In the future, the ELISA testing market is expected to grow as demand for rapid and efficient diagnostic solutions increases worldwide. Advances in laboratory automation and multiplex testing technologies are likely to enhance testing efficiency. As global healthcare systems emphasize early disease detection and personalized medicine, ELISA testing will continue to play a crucial role in diagnostics and research.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test type

• Sandwich ELISA
• Indirect ELISA
• Multiple and Portable ELISA
• Competitive ELISA

By Applications

• Immunology
• Inflammation
• Infectious Diseases
• Cancer
• Protein Quantification
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, American Laboratory Products Company ALPCO, BD Biosciences, BioRad Laboratories Inc, BioMrieux, OrthoClinical Diagnostics Inc, R D Systems Inc, ZEUS Scientific Inc, Enzo Life Sciences, Inc, Biolegand, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Sandwich ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Indirect ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Multiple and Portable ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Competitive ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY APPLICATIONS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Applications
• 5.2. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Inflammation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Protein Quantification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Test Type
  • 6.2.2 By Applications
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Test Type
  • 6.3.2 By Applications
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Test Type
  • 6.4.2 By Applications
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Test Type
  • 6.5.2 By Applications
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Test Type
  • 6.6.2 By Applications
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Thermo Fisher Scientific. Inc
  • 8.2.2 American Laboratory Products Company (ALPCO)
  • 8.2.3 BD Biosciences
  • 8.2.4 Bio-Rad Laboratories Inc
  • 8.2.5 BioMerieux
  • 8.2.6 Ortho-Clinical Diagnostics Inc
  • 8.2.7 R & D Systems Inc
  • 8.2.8 ZEUS Scientific Inc
  • 8.2.9 Enzo Life Sciences, Inc
  • 8.2.10 Biolegand, Inc